Author

Maurice M. Nigo

Observed names: Maurice Mutro Nigo, Maurice M Nigo, Maurice Mutro Nigo, Nigo, Maurice M., Nigo, Maurice Mutro

Observed institutions: Swiss Tropical and Public Health Institute, University of Basel, University Hospital of Basel, European Foundation for Clinical Nanomedicine, Institut Supérieur de Technique Médicale, ISTM Nyankunde

ORCID: 0009-0003-3987-3837

Observed ORCIDs: 0009-0003-3987-3837, 0000-0002-0687-5604

OpenAlex ID: A5065263380

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

2018 · Nicholas O Opoku, Didier K Bakajika, et al. · The Lancet · 304

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

2022 · Didier Bakajika, Eric M Kanza, et al. · PLoS neglected tropical diseases · 150

Filarial Antigenemia and Loa loa Night Blood Microfilaremia in an Area Without Bancroftian Filariasis in the Democratic Republic of Congo

2014 · Didier K. Bakajika, Maurice M. Nigo, et al. · American Journal of Tropical Medicine and Hygiene · 60

Diagnosing dengue virus infection: rapid tests and the role of micro/nanotechnologies

2015 · Bei Zhang, Georgette B. Salieb-Beugelaar, et al. · Nanomedicine Nanotechnology Biology and Medicine · 57

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

2023 · Klodeta Kura, Philip Milton, et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 30

Epidemiology of Schistosoma mansoni infection in Ituri Province, north-eastern Democratic Republic of the Congo

2021 · Maurice M Nigo, Peter Odermatt, et al. · PLoS neglected tropical diseases · 19

Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo

2021 · Maurice M Nigo, Peter Odermatt, et al. · PLoS neglected tropical diseases · 12

Schistosomiasis: from established diagnostic assays to emerging micro/nanotechnology-based rapid field testing for clinical management and epidemiology

2019 · Maurice Mutro Nigo, Georgette Salieb-Beugelaar, et al. · Precision Nanomedicine · 12

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

2024 · Eric M. Kanza, Amos Nyathirombo, et al. · Parasites & Vectors · 5

Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

2026 · Françoise N. Ngave, Deogratias U. Wonyarossi, et al. · Parasites & Vectors · 3

Improving diagnosis of pneumococcal disease by multiparameter testing and micro/nanotechnologies

2016 · Georgette B. Salieb-Beugelaar, Bei Zhang, et al. · European Journal of Nanomedicine · 3

Patients with severe schistosomiasis mansoni in Ituri Province, Democratic Republic of the Congo

2021 · Maurice M. Nigo, Peter Odermatt, et al. · Infectious Diseases of Poverty · 2

Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

2026 · Ngave, Françoise N., Wonyarossi, Deogratias U., et al. · Figshare

Additional file 1 of Onchocerca volvulus infection prevalence and intensity in Logo and Nyarambe Health Zones in Ituri, Democratic Republic of the Congo in 2010 and in 2021–2023: results of screening for clinical trials of moxidectin versus ivermectin

2026 · Ngave, Françoise N., Wonyarossi, Deogratias U., et al. · Figshare

Managing Bundibugyo Ebola Disease under Weak Contact Tracing and PPE Scarcity: Strategy Modelling for Scarce Emerging Vaccine Stock in Bunia/Ituri

2026 · Patrick Hunziker, Samuel Lemery Nigo, et al. · SSRN Electronic Journal

Schistosomiasis in Eastern Democratic Republic of the Congo: A major neglected healthcare concern

2020 · Nigo, Maurice Mutro · edoc (University of Basel)

Works count: 26

Citation count: 658

H-index: 8

I10-index: 8